To further investigate the prognostic prediction value of these three miRNAs, the survival analysis from our study did support the theory that miR-143 high expression played a protective role for AML patients with the presence of DNMT3A mutations. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.